IsoTis Receives Clearance for Accell Products

IsoTis, an orthobiologics company, announced the FDA has granted marketing clearance for its Accell family of products as Class II medical devices.

The products include the Accell 100, Accell Connexus and Accell Total Bone Matrix, as well as a new Accell product that is not currently marketed.

The products are indicated for use as bone graft extenders in the spine, extremities and pelvis, or as bone void fillers in extremities and the pelvis.